Task: Answer the multiple-choice question.
Query: Which drug exhibits a 0.932% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1ccc(NC(=O)c2cc(-c3cccs3)nc3ccccc23)nc1
b CCN(CC)C(=O)C1CCCN(C(=O)c2cc(COc3ccc4ncccc4c3)on2)C1
c COc1ccc(-c2csc3ncn(CC(=O)N4CCOCC4)c(=O)c23)cc1
d CC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
e Cc1cccc(N2CCN(C(=O)C3CCN(S(=O)(=O)c4cccc5cccnc45)CC3)CC2C)c1
Answer: d. CC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
CC(=O)NCCc1nc2cc(NC(=O)c3ccc(Cl)cc3)ccc2n1C
N-[2-(2-acetamidoethyl)-1-methylbenzimidazol-5-yl]-4-chlorobenzamide